Indo-Bangla Pharmaceuticals Limited suffered a 91.65 per cent dip in profit to Tk 11.62 lakh in the third quarter of the current financial year.

It made a profit of Tk 1.39 crore in the same quarter of 2021-22.

The EPS was Tk 0.01 in January-March of 2022-23 against Tk 0.12 in the same quarter of 2021-22, according to the unaudited financial statements.

The company made a profit of Tk 1.16 crore in July-March of FY23, down more than 83 per cent from the Tk 7.20 crore reported in the same period of FY22. As a result, the EPS plummeted to Tk 0.10 from Tk 0.62.

Indo-Bangla Pharmaceuticals' shares traded at Tk 17 on the Dhaka Stock Exchange today, unchanged from a session earlier.